Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Melanoma: Horses for courses.

McCarthy N.

Nat Rev Cancer. 2013 Apr;13(4):222. doi: 10.1038/nrc3491. Epub 2013 Feb 28. No abstract available.

PMID:
23446548
2.

Equine melanocytic tumors: a retrospective study of 53 horses (1988 to 1991).

Valentine BA.

J Vet Intern Med. 1995 Sep-Oct;9(5):291-7.

3.

In vitro anticancer activity of Betulinic acid and derivatives thereof on equine melanoma cell lines from grey horses and in vivo safety assessment of the compound NVX-207 in two horses.

Liebscher G, Vanchangiri K, Mueller T, Feige K, Cavalleri JM, Paschke R.

Chem Biol Interact. 2016 Feb 25;246:20-9. doi: 10.1016/j.cbi.2016.01.002. Epub 2016 Jan 7.

PMID:
26772157
4.

Constitutive activation of the ERK pathway in melanoma and skin melanocytes in Grey horses.

Jiang L, Campagne C, Sundström E, Sousa P, Imran S, Seltenhammer M, Pielberg G, Olsson MJ, Egidy G, Andersson L, Golovko A.

BMC Cancer. 2014 Nov 21;14:857. doi: 10.1186/1471-2407-14-857.

5.

Coat color genotypes and risk and severity of melanoma in gray quarter horses.

Teixeira RB, Rendahl AK, Anderson SM, Mickelson JR, Sigler D, Buchanan BR, Coleman RJ, McCue ME.

J Vet Intern Med. 2013 Sep-Oct;27(5):1201-8. doi: 10.1111/jvim.12133. Epub 2013 Jul 22.

6.

Double-blind placebo-controlled study with interleukin-18 and interleukin-12-encoding plasmid DNA shows antitumor effect in metastatic melanoma in gray horses.

Müller J, Feige K, Wunderlin P, Hödl A, Meli ML, Seltenhammer M, Grest P, Nicolson L, Schelling C, Heinzerling LM.

J Immunother. 2011 Jan;34(1):58-64. doi: 10.1097/CJI.0b013e3181fe1997.

PMID:
21150713
7.

Equine melanoma in a population of 296 grey Lipizzaner horses.

Seltenhammer MH, Simhofer H, Scherzer S, Zechner R, Curik I, Sölkner J, Brandt SM, Jansen B, Pehamberger H, Eisenmenger E.

Equine Vet J. 2003 Mar;35(2):153-7.

PMID:
12638791
8.

Comparative histopathology of grey-horse-melanoma and human malignant melanoma.

Seltenhammer MH, Heere-Ress E, Brandt S, Druml T, Jansen B, Pehamberger H, Niebauer GW.

Pigment Cell Res. 2004 Dec;17(6):674-81.

PMID:
15541026
9.

Melanoma as a cause of spinal cord compression in two horses.

Schott HC, Major MD, Grant BD, Bayly WM.

J Am Vet Med Assoc. 1990 Jun 1;196(11):1820-2.

PMID:
2351603
10.

Local and systemic effect of transfection-reagent formulated DNA vectors on equine melanoma.

Mählmann K, Feige K, Juhls C, Endmann A, Schuberth HJ, Oswald D, Hellige M, Doherr M, Cavalleri JM.

BMC Vet Res. 2015 Jun 11;11:132. doi: 10.1186/s12917-015-0422-9.

11.

Local and systemic effect of transfection-reagent formulated DNA vectors on equine melanoma.

Mählmann K, Feige K, Juhls C, Endmann A, Schuberth HJ, Oswald D, Hellige M, Doherr M, Cavalleri JM.

BMC Vet Res. 2015 May 14;11:107. doi: 10.1186/s12917-015-0414-9.

12.

Metastatic melanoma in horses.

MacGillivray KC, Sweeney RW, Del Piero F.

J Vet Intern Med. 2002 Jul-Aug;16(4):452-6.

13.

A cis-acting regulatory mutation causes premature hair graying and susceptibility to melanoma in the horse.

Rosengren Pielberg G, Golovko A, Sundström E, Curik I, Lennartsson J, Seltenhammer MH, Druml T, Binns M, Fitzsimmons C, Lindgren G, Sandberg K, Baumung R, Vetterlein M, Strömberg S, Grabherr M, Wade C, Lindblad-Toh K, Pontén F, Heldin CH, Sölkner J, Andersson L.

Nat Genet. 2008 Aug;40(8):1004-9. doi: 10.1038/ng.185. Epub 2008 Jul 20.

PMID:
18641652
14.

Copy number expansion of the STX17 duplication in melanoma tissue from Grey horses.

Sundström E, Imsland F, Mikko S, Wade C, Sigurdsson S, Pielberg GR, Golovko A, Curik I, Seltenhammer MH, Sölkner J, Lindblad-Toh K, Andersson L.

BMC Genomics. 2012 Aug 2;13:365. doi: 10.1186/1471-2164-13-365.

15.

The study of cutaneous melanomas in Camargue-type gray-skinned horses (2): epidemiological survey.

Fleury C, Bérard F, Leblond A, Faure C, Ganem N, Thomas L.

Pigment Cell Res. 2000 Feb;13(1):47-51.

PMID:
10761996
16.

In vivo induction of interferon gamma expression in grey horses with metastatic melanoma resulting from direct injection of plasmid DNA coding for equine interleukin 12.

Müller JM, Wissemann J, Meli ML, Dasen G, Lutz H, Heinzerling L, Feige K.

Schweiz Arch Tierheilkd. 2011 Nov;153(11):509-13. doi: 10.1024/0036-7281/a000262.

17.

[Peripheral leukocytes of melanoma-bearing and melanoma-free grey horses of various ages].

Mayr B, Niebauer GW, Gebhart W, Hofecker G, Kügl A, Schleger W.

Zentralbl Veterinarmed A. 1979 Jun;26(5):417-24. German. No abstract available.

PMID:
122775
18.

Immune response of healthy horses to DNA constructs formulated with a cationic lipid transfection reagent.

Schnabel CL, Steinig P, Koy M, Schuberth HJ, Juhls C, Oswald D, Wittig B, Willenbrock S, Murua Escobar H, Pfarrer C, Wagner B, Jaehnig P, Moritz A, Feige K, Cavalleri JM.

BMC Vet Res. 2015 Jun 23;11:140. doi: 10.1186/s12917-015-0452-3.

19.

Phase II clinical trials with rhizoxin in breast cancer and melanoma. The EORTC Early Clinical Trials Group.

Hanauske AR, Catimel G, Aamdal S, ten Bokkel Huinink W, Paridaens R, Pavlidis N, Kaye SB, te Velde A, Wanders J, Verweij J.

Br J Cancer. 1996 Feb;73(3):397-9.

20.

Establishment and characterization of a primary and a metastatic melanoma cell line from Grey horses.

Seltenhammer MH, Sundström E, Meisslitzer-Ruppitsch C, Cejka P, Kosiuk J, Neumüller J, Almeder M, Majdic O, Steinberger P, Losert UM, Stöckl J, Andersson L, Sölkner J, Vetterlein M, Golovko A.

In Vitro Cell Dev Biol Anim. 2014 Jan;50(1):56-65. doi: 10.1007/s11626-013-9678-1. Epub 2013 Aug 28.

PMID:
23982913

Supplemental Content

Support Center